EyePoint, Inc. (EYPT) Latest Filing Signal

Latest Filing: 10-K  |  Filed Mar 5, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for EyePoint, Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, EyePoint, Inc.'s filing signal continuing negative.
earningsVibe SuperAnalyst™ Verdict: CONTINUING NEGATIVE

Signal Performance — Stock Price Since Filing

30-Day Change
-16.81%
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Negative
GEMINI
Continuing Negative
CLAUDE
Turned Positive
CHATGPT
Continuing Negative

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does EyePoint, Inc. actually do?
Answer:
EyePoint, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for serious retinal diseases, leveraging its proprietary Durasert ETM bioerodible technology for sustained intraocular drug delivery. Its lead product candidate, DURAVYUTM, an investigational sustained delivery treatment for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME), combines vorolanib with the Durasert ETM technology. DURAVYU is currently in Phase 3 trials for both indications, with data expected in mid-2026 for wet AMD. The company also has EYP-2301, a TIE-2 agonist, in preclinical development. EyePoint is headquartered in Watertown, Massachusetts, with a commercial manufacturing facility in Northbridge, Massachusetts.
Question:
What are EyePoint, Inc.'s revenue drivers?
Answer:
Revenue is primarily driven by license and collaboration agreements, and royalty income from commercial partners. Product sales, though declining, also contribute.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required